Compare S H Kelkar & Co. with Similar Stocks
Stock DNA
Specialty Chemicals
INR 2,455 Cr (Small Cap)
28.00
39
0.59%
0.60
7.03%
1.76
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Aug-01-2025
Risk Adjusted Returns v/s 
Returns Beta
News

S H Kelkar & Company Ltd Hits Intraday High with 7.03% Surge on 9 Feb 2026
S H Kelkar & Company Ltd recorded a robust intraday performance on 09 Feb 2026, surging to an intraday high of Rs 181, marking a 6.94% rise from its previous close. The stock outperformed its sector and the broader market, reflecting strong trading momentum throughout the session.
Read full news article
S H Kelkar & Company Ltd Rating Upgraded to Sell Amid Mixed Technical and Financial Signals
S H Kelkar & Company Ltd, a key player in the Specialty Chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 6 February 2026. This change reflects a nuanced reassessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals. Despite ongoing challenges in financial performance, technical indicators have shown signs of stabilisation, prompting a more cautious but less negative outlook.
Read full news article
S H Kelkar & Company Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
S H Kelkar & Company Ltd has experienced a notable shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook. Despite a 4.62% gain on 9 Feb 2026, the specialty chemicals firm’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. Investors are advised to carefully analyse these developments in the context of the company’s recent price action and broader market trends.
Read full news article Announcements 
Corporate Action-Board approves Dividend
06-Feb-2026 | Source : BSEDeclaration of Interim Dividend for FY 2025-26
Announcement under Regulation 30 (LODR)-Acquisition
06-Feb-2026 | Source : BSES H Kelkar and Company Limited has informed the exchange about the approval of an additional equity investment of an amount not exceeding AED 5 Million by Keva Fragrances Private Limited wholly-owned subsidiary of the Company in Keva Middle East FZE wholly-owned subsidiary of Keva Fragrances Private Limited and in turn that of the Company.
Board Meeting Outcome for Outcome Of Board Meeting Held On February 06 2026
06-Feb-2026 | Source : BSEPlease refer enclosed file
Corporate Actions 
No Upcoming Board Meetings
S H Kelkar & Company Ltd has declared 10% dividend, ex-date: 13 Feb 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
5.662
Held by 5 Schemes (5.56%)
Held by 54 FIIs (6.79%)
Ramesh Vinayak Vaze Family Trust (ramesh Vaze, Prabha Vaze & Kedar Vaze-in The Capacity Of Trustee) (19.51%)
Firmenich Aromatics Production (india) Pvt Ltd (9.8%)
18.03%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 5.40% vs -4.61% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 255.77% vs -64.10% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 12.02% vs 12.42% in Sep 2024
Growth in half year ended Sep 2025 is 174.25% vs -182.77% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 10.43% vs 13.36% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 330.23% vs -132.99% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 15.35% vs 9.15% in Mar 2024
YoY Growth in year ended Mar 2025 is -40.17% vs 100.13% in Mar 2024






